Publications by authors named "Jing C Xiao"

Claim this Profile
C
Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumannii.
Hao Wang, Andrii Ishchenko, Jason Skudlarek, Pamela Shen, Liudmila Dzhekieva, Jing Chen Xiao

Nat Microbiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant .
Donna Carr, Zufei Zhang, Qian Si, Fred Racine, Jing Chen Xiao

Open Forum Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model.
Jin Wu, Fred Racine, Michael K Wismer, Katherine Young, Donna M Carr, Jing C Xiao

Antimicrob Agents Chemother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus.
Shu-Wei Yang, Jianping Pan, Christine Yang, Marc Labroli, Weidong Pan, Jing C Xiao

Bioorg Med Chem Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon receptor antagonism induces increased cholesterol absorption.
Hong-Ping Guan, Xiaodong Yang, Ku Lu, Sheng-Ping Wang, Jose M Castro-Perez, Jing Chen Xiao

J Lipid Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice.
Gregory M Dillon, Laura S Lubbers, Mitchell T Ferguson, Julie Z Lao, Ruey-Ruey C Huang, Jing C Xiao

Behav Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation.
Christina B Madsen-Duggan, John S Debenham, Thomas F Walsh, Lin Yan, Pei Huo, Jing Chen Xiao

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.
Lin Yan, Pei Huo, John S Debenham, Christina B Madsen-Duggan, Julie Lao, Jing Chen Xiao

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: synthesis and biological evaluation. Part 1.
John S Debenham, Christina B Madsen-Duggan, Richard B Toupence, Thomas F Walsh, Junying Wang, Jing Chen Xiao

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists.
Wu Du, James P Jewell, Linus S Lin, Vincent J Colandrea, Jing C Xiao

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation.
John S Debenham, Christina B Madsen-Duggan, Junying Wang, Xinchun Tong, Julie Lao, Jing Chen Xiao

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.
Petr Vachal, Joan M Fletcher, Tung M Fong, Cathy C R-R Huang, Julie Lao, Jing C Xiao

J Med Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells.
Jing Chen Xiao, James P Jewell, Linus S Lin, William K Hagmann, Tung M Fong

Brain Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist.
Linus S Lin, Sookhee Ha, Richard G Ball, Nancy N Tsou, Laurie A Castonguay, Jing Chen Xiao

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Richard Z Chen, Andrea Frassetto, Julie Z Lao, Ruey-Ruey C Huang, Jing C Xiao

Eur J Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
Tung M Fong, Xiao-Ming Guan, Donald J Marsh, Chun-Pyn Shen, D Sloan Stribling, Jing C Xiao

J Pharmacol Exp Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists.
Christina B Madsen-Duggan, John S Debenham, Thomas F Walsh, Richard B Toupence, Song X Huang, Jing Chen Xiao

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity.
Linus S Lin, Thomas J Lanza, James P Jewell, Ping Liu, Shrenik K Shah, Jing Chen Xiao

J Med Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor.
Jiaping Zhang, Chun-Pyn Shen, Jing C Xiao, Thomas J Lanza, Linus S Lin

Eur J Pharmacol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists.
John S Debenham, Christina B Madsen-Duggan, Thomas F Walsh, Junying Wang, Xinchun Tong, Jing Chen Xiao

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
Chun-Pyn Shen, Jing Chen Xiao, Helen Armstrong, William Hagmann, Tung M Fong

Eur J Pharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis